This is just another opinion in a sea of them.
It would appear that no tire kicking is happening currently, and that we aren't well known. Hence the need for the roadshow and engaging Tanis PR. The hope is that our game changing / world changing tech is flying under the radar, not that it's 'known' and undesirable for reasons unknown. Not sure if I missed it, but there seems to have been very little disclosed about the meeting DM had with IMEC, aside from they are excited about the tech but don't want to show us favoritism. Has the Company provided more detail that this? I am interpreting the above as, they are excited about the 'potential' (like our 'potential' customers), but don't want to go out on a limb until more is demonstrated / proved via Platform Lot 5 and 6. Perhaps their reservations come from the very long development pathway to date, and the fact that we had a few failures along the way (which would be understandable).
Notwithstanding the above comments, it looks like the Company is moving in the right direction both from a development and marketing perspective. As such, risk appears to be to the upside based on the current SP. Obviously, the biggest downside risk is PLT 5 & 6 success / failure. Nevertheless, as another poster pointed out, SP is at the mercy of Institutions until major news is announced.
GLTAH!
- Forums
- ASX - By Stock
- 4DS
- Ann: 4DS Australian Open Briefings Presentation
Ann: 4DS Australian Open Briefings Presentation, page-423
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.1¢ |
Change
0.011(15.7%) |
Mkt cap ! $142.8M |
Open | High | Low | Value | Volume |
7.1¢ | 8.3¢ | 7.1¢ | $439.5K | 5.520M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 495612 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.1¢ | 7600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 495612 | 0.080 |
4 | 78895 | 0.079 |
3 | 174500 | 0.078 |
3 | 120000 | 0.077 |
4 | 978190 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.081 | 7600 | 1 |
0.082 | 250224 | 2 |
0.083 | 32036 | 2 |
0.084 | 150000 | 1 |
0.085 | 412802 | 3 |
Last trade - 15.57pm 24/09/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online